✦ LIBER ✦

OR.85. Leukocyte Responses during Recombinant Human Interleukin-21 Treatment of Patients with Stage IV Melanoma

✍ Scribed by Kresten Skak; Klaus Stensgaard Frederiksen; Jenny Lau; Ulrik Mouritzen; Grant McArthur; Ian Davis; Birte K. Skrumsager; Mary Sartor; Rune Overgaard; Dorthe Lundsgaard; Lasse Tengbjerg Hansen

Book ID: 113540235
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 42 KB
Volume: 127
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2008.03.092

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined Pharmacodynamic and Transcripto

Combined Pharmacodynamic and Transcriptome Profiling of Recombinant Human Interleukin-21 Responses in Patients with Stage IV Malignant Melanoma

✍ Dorthe Lundsgaard; Klaus Stensgaard Frederiksen; Lasse Tengbjerg Hansen; Birte K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

408 POSTER Phase 1 study of recombinant

408 POSTER Phase 1 study of recombinant human Interleukin-21 (rIL-21) in combination with sunitinib in patients with stage IV renal cell carcinoma

✍ V. Grünwald; I. Desar; J. Haanen; W. Fiedler; M.B. Olsen; C.M.L. van Herpen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Overlapping human leukocyte antigen clas

Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma : Evidence of systemic immune dysfunction

✍ Melanoma Study Group of the Mayo Clinic Cancer Center ; Esteban Celis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

## Abstract ## BACKGROUND. MPS160 (GRAMLGTHTMEVTV) is a glycoprotein 100‐derived melanoma peptide that contains overlapping human leukemic antigen A2‐, DR53‐, and DQw6‐restricted T‐cell epitopes. In preclinical testing, MPS160 demonstrated superior immunization and antitumor activity. In this repo

265 POSTER Recombinant human Interleukin

265 POSTER Recombinant human Interleukin-21 (rIL-21), a new cytokine for immunotherapy: results of two phase 1 studies in patients with metastatic melanoma (MM) or renal cell carcinoma (RCC)

✍ I.D. Davis; B.G. Redman; G. McArthur; B.D. Curti; J. Cebon; B.K. Skrumsager; E.L 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Chemo-immunotherapy in patients with met

Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response

✍ Rut Isacson; Eli Kedar; Vivian Barak; Zulma Gazit; Oded Yurim; Inna Kalichman; H 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 576 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB